{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:11:32Z","timestamp":1761948692125,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vhri.2020.06.002","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T10:12:23Z","timestamp":1612347143000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus\u2013Infected Adults on Antiretroviral Therapy"],"prefix":"10.1016","volume":"24","author":[{"given":"Gurprit","family":"Grover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanya","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vhri.2020.06.002_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4103\/1947-2714.172853","article-title":"HIV\/AIDS Prevention and Control in India: Achievements and Future Challenges","volume":"7","author":"Pandve","year":"2015","journal-title":"North Am J Med Sci"},{"issue":"4","key":"10.1016\/j.vhri.2020.06.002_bib4","first-page":"824","article-title":"Opportunistic infections among HIV patients attending tertiary care hospital, Karnataka, India","volume":"3","author":"Goud","year":"2014","journal-title":"Int J Curr Microbiol Appl Sci"},{"issue":"11","key":"10.1016\/j.vhri.2020.06.002_bib5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM200103153441108","article-title":"The cost effectiveness of combination antiretroviral therapy for HIV disease","volume":"344","author":"Freedberg","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.vhri.2020.06.002_bib6","first-page":"1","article-title":"Guidelines for prevention and treatment opportunistic infections in HIV-infected adults and adolescents; recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association\/Infectious Diseases Society of America","volume":"58","author":"Benson","year":"2009","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vhri.2020.06.002_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.6000\/1929-6029.2013.02.02.08","article-title":"A\u00a0multistate Markov model based on CD4 cell count for HIV\/AIDS patients on antiretroviral therapy (ART)","volume":"2","author":"Grover","year":"2013","journal-title":"Int J Stat Med Res"},{"issue":"2","key":"10.1016\/j.vhri.2020.06.002_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/QAD.0b013e328320accc","article-title":"Economic analysis of HIV prevention interventions in Andhra Pradesh state of India to inform resource allocation","volume":"23","author":"Dandona","year":"2009","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib9","first-page":"10","article-title":"Rate of hospitalization and inpatient care costs for HIV-1-infected patients in Pune, India","volume":"19","author":"Ghate","year":"2006","journal-title":"Natl Med J India"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1472-6963-10-117","article-title":"(2010). Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India","volume":"10","author":"Dandona","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"10.1016\/j.vhri.2020.06.002_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168512","article-title":"A\u00a0systematic review of cost-effectiveness studies reporting cost-per-DALY averted","volume":"11","author":"Neumann","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11904-016-0303-2","article-title":"Modeling and cost-effectiveness in HIV prevention","volume":"13","author":"Jacobsen","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1756-0500-6-534","article-title":"Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia","volume":"6","author":"Damtie","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vhri.2020.06.002_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijid.2008.03.029","article-title":"Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts","volume":"13","author":"Ghate","year":"2008","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vhri.2020.06.002_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1743-422X-8-116","article-title":"Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata","volume":"8","author":"Saha","year":"2011","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vhri.2020.06.002_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/2589-0557.216992","article-title":"Current trends in opportunistic infections in children living with HIV\/AIDS in a tertiary care hospital in Northern India","volume":"38","author":"Dhaka","year":"2017","journal-title":"Indian J Sex Transm Dis AIDS"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib19","first-page":"22","article-title":"AIDS-Related diarrhea\u2013pathogenesis, evaluation and treatment","volume":"14","author":"Zacharof","year":"2001","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.vhri.2020.06.002_bib17","first-page":"219","article-title":"Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions","volume":"2","author":"Elfstrand","year":"2010","journal-title":"HIV\/AIDS (Auckl)"},{"issue":"15","key":"10.1016\/j.vhri.2020.06.002_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"year":"2016","series-title":"Measuring the Burden of Disease: Disability Adjusted Life Year (DALY)","author":"Donev","key":"10.1016\/j.vhri.2020.06.002_bib21"},{"issue":"3","key":"10.1016\/j.vhri.2020.06.002_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00038-014-0552-z","article-title":"Calculating disability-adjusted life years to quantify burden of disease","volume":"59","author":"Devleesschauwer","year":"2014","journal-title":"Int J Public Health"},{"issue":"3","key":"10.1016\/j.vhri.2020.06.002_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/heapol\/16.3.326","article-title":"Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis","volume":"16","author":"Rushby","year":"2001","journal-title":"Health Policy Plan"},{"year":"1996","series-title":"The Global Burden Of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020: Summary","author":"Murray","key":"10.1016\/j.vhri.2020.06.002_bib24"},{"year":"1994","series-title":"Global Comparative Assessments In The Health Sector: Disease Burden, Expenditures and Intervention Packages","author":"Murray","key":"10.1016\/j.vhri.2020.06.002_bib25"},{"year":"2016","series-title":"Global Burden of Disease Study 2015 (GBD 2015) Disability Weights","key":"10.1016\/j.vhri.2020.06.002_bib26"},{"issue":"4","key":"10.1016\/j.vhri.2020.06.002_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1524-4733.2004.74002.x","article-title":"(2004). Discounting health outcomes in economic\u00a0evaluation: the ongoing debate","volume":"7","author":"Severens","year":"2004","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.vhri.2020.06.002_bib39","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40273-015-0309-4","article-title":"Dealing with time in health economic evaluation: methodological issues and recommendations for practice","volume":"33","author":"O\u2019Mahony","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.vhri.2020.06.002_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hec.678","article-title":"Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis","volume":"11","author":"Hoch","year":"2002","journal-title":"Health Econ"},{"key":"10.1016\/j.vhri.2020.06.002_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2014","journal-title":"Bull World Health Org"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0253-7176.70523","article-title":"Clinico-epidemiological and socio-behavioral study\u00a0of people living with HIV\/AIDS","volume":"32","author":"Khan","year":"2010","journal-title":"Indian J Psychol Med"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5455\/jcer.201314","article-title":"Drug utilization study of HIV positive patients registered with antiretroviral therapy centre of a tertiary care hospital","volume":"1","author":"Jiyo","year":"2013","journal-title":"J\u00a0Clin Experimental Res"},{"issue":"12","key":"10.1016\/j.vhri.2020.06.002_bib32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.5588\/ijtld.14.0108","article-title":"Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB\/HIV in Rio (THRio) Study","volume":"18","author":"Azadi","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vhri.2020.06.002_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11938-006-0021-8","article-title":"(2006). Diarrhea in patients with AIDS","volume":"9","author":"Morpeth","year":"2006","journal-title":"Curr Treat Options Gastroenterol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109920300467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109920300467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:14:14Z","timestamp":1761941654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109920300467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"alternative-id":["S2212109920300467"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2020.06.002","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus\u2013Infected Adults on Antiretroviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}